Stay updated on Pembrolizumab and TKI in CML MRD Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab and TKI in CML MRD Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab and TKI in CML MRD Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.6.3 to v3.6.4, reflecting an update to the page's underlying system or template.
    Difference
    0.0%
    Check dated 2026-07-25T13:05:50.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The page shows added and removed date markers (e.g., 2026-07-17, 2026-07-16, 2026-07) indicating update timestamps for the study record, suggesting administrative maintenance rather than content changes. This reflects maintenance activity rather than alterations to the trial information.
    Difference
    0.1%
    Check dated 2026-07-18T09:29:21.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    No additions or deletions were provided, so there are no identifiable changes to the page content.
    Difference
    0.0%
    Check dated 2026-07-11T06:43:11.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The study record page now shows Revision: v3.6.3, replacing the previous v3.6.2. This reflects an updated version of the page rendering rather than a change to the study data.
    Difference
    0.0%
    Check dated 2026-07-04T03:51:33.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.0 to v3.6.2 on the Study Details page, representing a backend/content update to the page without altering the study data shown.
    Difference
    0.0%
    Check dated 2026-06-26T20:04:42.000Z thumbnail image
  7. Check
    47 days ago
    Change Detected
    Summary
    The study record's timestamps were updated, adding June 2026 updates and removing earlier March–April entries, reflecting routine registry maintenance rather than substantive content changes.
    Difference
    0.1%
    Check dated 2026-06-19T17:39:10.000Z thumbnail image

Stay in the know with updates to Pembrolizumab and TKI in CML MRD Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and TKI in CML MRD Clinical Trial page.